Li et al. proposed that Baicalein can serve as a sensitizer for DDP chemotherapy drugs due to its ability to induce apoptosis and autophagy in GC cells by modulating AKT/mTOR and oxidative stress-related Nrf2/kidney injury molecule-1 (Keap-1) pathways (Li P. et al., 2020). The gene discussed is AKT1; the disease is gastric cancer.